Buy Functional Study of Zebrafish Flt3 in Embryonic Hematopoiesis with Particular Reference to Modeling Human Flt3/Itd AML
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Home > Medicine & Health Science textbooks > Medicine: general issues > Functional Study of Zebrafish Flt3 in Embryonic Hematopoiesis with Particular Reference to Modeling Human Flt3/Itd AML
Functional Study of Zebrafish Flt3 in Embryonic Hematopoiesis with Particular Reference to Modeling Human Flt3/Itd AML

Functional Study of Zebrafish Flt3 in Embryonic Hematopoiesis with Particular Reference to Modeling Human Flt3/Itd AML


     0     
5
4
3
2
1



Out of Stock


Notify me when this book is in stock
X
About the Book

This dissertation, "Functional study of zebrafish Flt3 in embryonic hematopoiesis with particular reference to modeling human FLT3/ITD AML" by Bailiang, He, 何柏亮, was obtained from The University of Hong Kong (Pokfulam, Hong Kong) and is being sold pursuant to Creative Commons: Attribution 3.0 Hong Kong License. The content of this dissertation has not been altered in any way. We have altered the formatting in order to facilitate the ease of printing and reading of the dissertation. All rights not granted by the above license are retained by the author. Abstract: FMS-like tyrosine kinase 3 (FLT3) is expressed in human hematopoietic stem and progenitor cells (HSPC) but its role during embryogenesis is unclear. In acute myeloid leukemia (AML), internal tandem duplications (ITD) of FLT3 at the juxtamembrane domain (JMD) (FLT3/ITD) occur in 30% of patients and are associated with inferior clinical prognosis. Tyrosine kinase domain (TKD) mutations (FLT3/TKD) occur in 5% of cases and their prognostic significance is unclear. Both mutations result in constitutive activation of FLT3 signaling. In this project, zebrafish was used to examine the role of flt3 in developmental hematopoiesis and model human FLT3/ITD+ and FLT3/TKD+ AML in this organism. The JMD and TKD regions of zebrafish Flt3 were remarkably similar to their mammalian counterparts. Knockdown of flt3 by morpholino significantly reduced the expression of l-plastin (pan-leukocyte), csf1r and mpeg1 (macrophage) as well as that of c-myb (definitive HSPC), lck and rag1 (T-lymphocyte) shown by whole mount in situ hybridization (WISH). Expression of human FLT3/ITD in zebrafish embryos by plasmid DNA injection resulted in Stat5, Erk1/2, and Akt phosphorylation and the expansion of myeloid cells (pu.1+, mpo+, and cebpα+). The latter was ameliorated by FLT3 inhibitor quizartinib (formerly AC220). Human FLT3/TKD (D835Y) induced significant, albeit modest, myeloid expansion resistant to quizartinib, corroborating with their clinical responses to FLT3 inhibitors. Intriguingly, injection of FLT3/ITD mRNA induced dorsal axis duplication with duplicated expression of notochord marker col9a2 at 24 hours-post-fertilization (hpf). The effects could be ameliorated by quizartinib. To identify the initiating signals associated with axis duplication, expression of genes associated with dorsoventral patterning was examined at shield stage (6 hpf). The Spemann's organizer was expanded as evidenced by increased and ectopic expression of goosecoid (gsc), chordin (chd) and follistatin (fst). The up-regulation of Fst was confirmed by quantitative RT-QPCR and Western Blot. Interestingly, FST protein expression and STAT5 phosphorylation were significantly up-regulated in FLT3/ITD-transfected Hela cells, as well as in BaF3 cells expressing FLT3/ITD and FLT3/ITD+ AML cell lines MV4-11 and MOLM-13. FST transcript, protein expression (in cell) and protein secretion (in serum) were significantly increased in FLT3/ITD+ AML samples. Importantly, quizartinib significantly inhibited FST expression and FST knockdown significantly reduced leukemia growth of MV4-11 cells in vitro. This study provided novel insight to the role of flt3 during hematopoiesis, established a zebrafish model expressing of FLT3/ITD and FLT3/TKD mutation from AML, and identified FST as a novel molecular target of FLT3/ITD+ AML whose therapeutic potential should be further evaluated. Subjects: Protein-tyrosine kinase Zebra danio - Embryos Hematopoiesis


Best Sellers


Product Details
  • ISBN-13: 9781361028810
  • Publisher: Open Dissertation Press
  • Publisher Imprint: Open Dissertation Press
  • Height: 279 mm
  • No of Pages: 138
  • Weight: 336 gr
  • ISBN-10: 1361028815
  • Publisher Date: 26 Jan 2017
  • Binding: Paperback
  • Language: English
  • Spine Width: 8 mm
  • Width: 216 mm


Similar Products

Add Photo
Add Photo

Customer Reviews

REVIEWS      0     
Click Here To Be The First to Review this Product
Functional Study of Zebrafish Flt3 in Embryonic Hematopoiesis with Particular Reference to Modeling Human Flt3/Itd AML
Open Dissertation Press -
Functional Study of Zebrafish Flt3 in Embryonic Hematopoiesis with Particular Reference to Modeling Human Flt3/Itd AML
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

Functional Study of Zebrafish Flt3 in Embryonic Hematopoiesis with Particular Reference to Modeling Human Flt3/Itd AML

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept

    Fresh on the Shelf


    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!